PIB Headquarters
PIB’S BULLETIN ON COVID-19
|
|
- 86.01 Cr. vaccine doses have been administered so far under Nationwide Vaccination Drive
- Active cases account for less than 1% of total cases, currently at 0.89%
- India's Active caseload stands at 2,99,620; lowest in 191 days
- 26,041 new cases in the last 24 hours
- Recovery Rate currently at 97.78%
- 29,621 recoveries in the last 24 hours increases Total Recoveries to 3,29,31,972
- Weekly Positivity Rate  less than 3% for last 94 days
- Daily positivity rate  less than 3% for last 28 days
- 56.44 crore Total Tests conducted so far
#Unite2FightCorona#IndiaFightsCorona
PRESS INFORMATION BUREAU
MINISTRY OF INFORMATION & BROADCASTING
GOVERNMENT OF INDIA
COVID-19 Update
India’s Cumulative COVID-19 Vaccination Coverage crosses the landmark of 86Cr
More than 38 Lakh doses administered in the last 24 hours
Recovery Rate currently at 97.78%
26,041 New Cases reported in the last 24 hours
India's Active Caseload  is 0.89% of Total Cases
Weekly Positivity Rate  less than 3% for last 94 days
With the administration of 38,18,362 vaccine doses in the last 24 hours, India’s COVID-19 vaccination coverage crossed the landmark of 86Cr  as per provisional reports till 7 am today. This has been achieved through 84,07,679 sessions.
The break-up of the cumulative figureas per the provisional report till 7 am today include:
|
|
HCWs
|
|
1st Dose
|
|
1,03,71,418
|
|
2nd Dose
|
|
88,35,377
|
|
FLWs
|
|
1st Dose
|
|
1,83,49,453
|
|
2nd Dose
|
|
1,48,33,709
|
|
Age Group 18-44 years
|
|
1st Dose
|
|
34,82,66,215
|
|
2nd Dose
|
|
7,45,08,007
|
|
Age Group 45-59 years
|
|
1st Dose
|
|
15,64,81,731
|
|
2nd Dose
|
|
7,39,69,804
|
|
Over 60 years
|
|
1st Dose
|
|
9,97,47,469
|
|
2nd Dose
|
|
5,47,95,828
|
|
Total
|
|
86,01,59,011
The recovery of 29,621 patients in the last 24 hours has increased the cumulative tally of recovered patients  to 3,29,31,972.
Consequently, India’s recovery rate stands at 97.78%. Recovery Rate is currently at its highest peak since March 2020.
Sustained and collaborative efforts by the Centre and the States/UTs continue the trend of less than 50,000 Daily New Cases that is being reported for 92 consecutive days now.
26,041 new cases were reported in the last 24 hours.
The Active Caseload is presently2,99,620. Active cases presently constitute 0.89% of the country's total Positive Cases.
The testing capacity across the country continues to be expanded. The last 24 hours saw a total of
11,65,006tests being conducted. India has so far conducted over 56.44 Cr  cumulative tests.
While testing capacity has been enhanced across the country, Weekly Positivity Rate at 1.94% remains less than 3% for the last 94 days now. The Daily Positivity rate reported to be 2.24%. The daily Positivity rate has remained below3% for last 28 days and below 5% for 111 consecutive days now.
Details: https://pib.gov.in/PressReleasePage.aspx?PRID=1758458
Update on COVID-19 Vaccine Availability in States/UTs
More than 84.50 Crore vaccine doses provided to States/UTs
More than 4.74 Crore balance and unutilized vaccine doses still available with States/UTswith nearly 21 Lakh doses in Pipeline
As part of the nationwide vaccination drive, Government of India has been supporting the States and UTs by providing them COVID Vaccines free of cost. In the new phase of the universalization of the COVID19 vaccination drive, the Union Government will procure and supply  75% of the vaccines being produced by the vaccinemanufacturers in the country to States and UTs.
|
|
VACCINE DOSES
|
|

|
|
SUPPLIED
|
|
84,50,28,655
|
|
PIPELINE
|
|
20,95,870
|
|
BALANCE AVAILABLE
|
|
4,74,80,540
More than 84.50 crore  vaccine doses have been provided to States/UTs so far through Govt of India  and through direct state procurement category.Further,nearly 21 Lakh doses  are in the pipeline.
More than 4.74Cr  balance and unutilized COVID Vaccine doses are still available with the States/UTs to be administered.
Details: https://pib.gov.in/PressReleasePage.aspx?PRID=1758469
Indo-US Health Dialogue 2021
Union Minister of State for Health and Family Welfare addresses 4th Indo-US Health Dialogue
“Collaboration between our countries will advance scientific discovery and management of global health threats.”: Dr. Bharati Pravin Pawar
The Minister put in foreground the mutual solidarity between both sides during the COVID-19 pandemic, where both sides extended their relentless support. She commended the way in which India and the U.S. have enhanced collaboration in research and development, especially with respect to pharmaceuticals, therapeutics, and vaccine development, which could be seen in Indian vaccine companies collaborating with US based agencies to develop COVID-19 vaccine.
Details: https://pib.gov.in/PressReleasePage.aspx?PRID=1758507
Important Tweets